Synapse - Radioimmunotherapy for high-risk and recurrent central nervous system (CNS) cancers: Results of a phase II study with intra-ommaya I-131-3f8

Radioimmunotherapy for high-risk and recurrent central nervous system (CNS) cancers: Results of a phase II study with intra-ommaya I-131-3f8 Meeting Abstract

Authors:	Kramer, K.; Smith-Jones, P. M.; Humm, J. L.; Zanzonico, P. B.; Pandit-Taskar, N.; Carrasquillo, J. A.; Modak, S.; Tickoo, S.; Gerald, W. L.; Dunkel, I. J.; Khakoo, Y.; Gilheeney, S. W.; Souweidane, M. M.; Larson, S. M.; Cheung, N. V.
Abstract Title:	Radioimmunotherapy for high-risk and recurrent central nervous system (CNS) cancers: Results of a phase II study with intra-ommaya I-131-3f8
Meeting Title:	14th International Symposium on Pediatric Neuro-Oncology (ISPNO)
Journal Title:	Neuro-Oncology
Volume:	12
Issue:	6
Meeting Dates:	2010 Jun 20-23
Meeting Location:	Vienna, Austria
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2010-06-01
Start Page:	ii43
Language:	English
ACCESSION:	ISI:000278817700196
PROVIDER:	wos
DOI:	10.1093/neuonc/noq043
PMCID:	PMC2940641
Notes:	--- - Meeting Abstract: DRUG.10 - "Source: Wos"